BC
COLL icon

Burney Company’s Collegium Pharmaceutical COLL Stock Holding History

Burney Company’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,476
Closed -$988K – 578
2024
Q4 		$988K Sell
34,476
-38,157
-53% -$1.26M 0.03% 316
2024
Q3 		$2.81M Buy
+72,633
New +$2.59M 0.1% 180

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Burney Company's COLL Position: Q1 2025 in Review

Burney Company sold out of Collegium Pharmaceutical (COLL) in Q1 2025, closing a stake of 34,476 shares — an estimated $988K sold.

Burney Company first reported a position in COLL in Q3 2024 and held it in 2 quarters. The position peaked at $2.81M in Q3 2024. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

  • Burney Company reported no remaining Collegium Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Burney Company sold 34,476 Collegium Pharmaceutical shares in Q1 2025, an estimated $988K.
  • Burney Company first reported a position in Collegium Pharmaceutical in Q3 2024 and held it in 2 quarters.
  • Burney Company's Collegium Pharmaceutical position peaked at $2.81M in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Burney Company's 13F filing for Q1 2025, filed 6 May 2025.